An Unusual Consult
Dr. Moll talks about his experience with an unusual consult as a coagulationist observing an adult, male lemur with a "lame leg" from Duke Lemur Center.
A Step Forward in the Treatment of Adolescent and Young Adult B-cell Acute Lymphoblastic Leukemia
Dr. Boulware and Dr. O'Dwyer discuss a study that tested the efficacy and feasibility of a pediatric regimen for adolescent and young adult patients with newly diagnosed B-
Dr. Kahl discusses the ESCHELON-2 study, a CD30+ T-cell lymphoma trial using a "repeal and replace" strategy, eliminating vincristine from the experimental regimen and substituting in BV.
Dr. Linkins discusses the VERDICT trial which compares reduced doses of apixaban and rivaroxaban with standard-of-care in adult patients with symptomatic proximal DVT or PE and moderate or severe renal insufficiency.
Drs. Adam Cuker and Aaron Gerds discuss the upcoming 7th edition of ASH-SAP, including new content and an updated multimedia program with illustrated and 3D animation.
March/April 2019Volume 16, Issue 2
View all Features articles
View all Diffusion articles
Dr. Silverstein discusses the importance and challenges of managing conflicts of interest in medical science.
View all president's column articles
View all Ask the Hematologist articles
View all Clinical Trials Corner articles
View all Mini Review articles
ASH continues to increase its efforts to expand and enhance the Society’s reach. NIH funding, efforts to ensure patient access to drugs, and sickle cell disease were top priorities on ASH’s advocacy agenda in 2018.
ASH continues to invest in and explore the important actions needed to make a significant difference in sickle cell disease (SCD) access to care, research, and global issues. Learn about the major advocacy-related initiatives undertaken by ASH in 2018.
In 2018, ASH worked to ensure patient access to care through a number of methods including ensuring drug access, pain management-related issues, and the Affordable Care Act.
In 2018, ASH commented on numerous rules and regulations proposed by the Centers for Medicare and Medicaid Services (CMS), which impact physician payment. ASH is actively involved in various advisory committees and also continues to engage with lawmakers on Capitol Hill.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology